♟️ Saturday 12 September 2026 Sat, 12 Sept 2026

Rare earths, scandium and biotech stocks led the week’s gains, while a rights issue sent Green & Gold Minerals sharply lower. Large capital raisings, mine funding and takeover activity kept resources at the centre of investor attention.

Listed funds dominated the week, with large share-price falls in L1 Group and Regal Investment Fund while Pacific Current rose after rejecting a takeover proposal. Results were stronger for several investment vehicles, but smaller companies still faced cash, funding and disclosure problems.

Critical minerals led the market, with Australasian Metals doubling after taking an option over West African lithium projects. Rare earth technology, scandium finance and gold drilling also drew attention, but many developers fell as investors questioned funding and delivery.

Neurizon and Clever Culture Systems led the week with 35.71% gains, while CONNEQT also rose despite giving back part of its reopening move.
Biotech trial funding, device manufacturing and healthcare launches shaped investor decisions across the sector.

FBR and Thrive Tribe fell heavily as investors weighed fresh funding and unproven commercial targets. Government contracts, recurring revenue and data centre plans gave the technology sector some stronger stories.